InMed Pharmaceuticals Inc. reports governance changes

InMed Pharmaceuticals Inc. filed an 8-K covering charter, bylaw or fiscal-year changes, a shareholder vote, and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.